IRAK3 is upregulated in rheumatoid arthritis synovium and delays the onset of experimental arthritis

Abstract excerpt

Tumour necrosis factor (TNF) is a potent inducer of endotoxin tolerance-associated molecules, such as interleukin-1 receptor-associated kinase 3 (IRAK3), and also a therapeutic target in inflammatory autoimmune diseases, as it upregulates the production of inflammatory mediators. The role of IRAK3 was assessed in rheumatoid arthritis (RA), a disease which is amenable to TNF blockade. As a variant of IRAK3 lacks...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to interferon and immune responses
• Share to NF-κB Signaling Pathways
• Share to Rheumatoid Arthritis Research and Therapies